Halozyme Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $261.5M
Liabilities Breakdown FY2016
Total Liabilities: $294.0M
Asset Breakdown
Total Assets: $261.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $66.8M | 25.5% |
| Accounts Receivable | $15.7M | 6.0% |
| Inventory | $14.6M | 5.6% |
| Property, Plant & Equipment | $4.3M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $160.2M | 61.3% |
Liabilities Breakdown
Total Liabilities: $294.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 1.2% |
| Long-Term Debt | $199.2M | 67.8% |
| Other Liabilities | $91.2M | 31.0% |